Perrigo Company plc logo

Perrigo Company plc (PIG)

Market Closed
5 Dec, 20:00
XFRA XFRA
11. 43
-0.41
-3.51%
- Market Cap
- P/E Ratio
1.1% Div Yield
300 Volume
2.35 Eps
11.84
Previous Close
Day Range
11.43 11.43
Year Range
10.51 29.31
Want to track PIG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days

Summary

PIG closed Friday lower at €11.43, a decrease of 3.51% from Thursday's close, completing a monthly increase of 0.18% or €0.02. Over the past 12 months, PIG stock lost -53.8%.
PIG pays dividends to its shareholders, with the most recent payment made on Sep 16, 2025. The next announced payment will be in In 1 weeks on Dec 16, 2025 for a total of €0.29.
The last earnings report, released on Nov 05, 2025, missed the consensus estimates by -0.77%. On average, the company has fell short of earnings expectations by -0.26%, based on the last three reports. The next scheduled earnings report is due on Feb 26, 2026.
Perrigo Company plc has completed 1 stock splits, with the recent split occurring on Aug 26, 1993.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

PIG Chart

Perrigo Q3 Earnings Beat, Sales Miss, Stock Falls on '25 View Cut

Perrigo Q3 Earnings Beat, Sales Miss, Stock Falls on '25 View Cut

PRGO beats Q3 earnings estimates but misses on sales. It also trims the 2025 outlook and launches a strategic review of its infant formula unit.

Zacks | 1 month ago
Perrigo Company plc (PRGO) Q3 2025 Earnings Call Transcript

Perrigo Company plc (PRGO) Q3 2025 Earnings Call Transcript

Perrigo Company plc ( PRGO ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Bradley Joseph - Vice President of Global Investor Relations & Corporate Communications Patrick Lockwood-Taylor - President, CEO & Director Eduardo Bezerra - Executive VP & CFO Conference Call Participants Susan Anderson - Canaccord Genuity Corp., Research Division Keith Devas - Jefferies LLC, Research Division Ethan Brown - JPMorgan Chase & Co, Research Division Daniel Biolsi - Hedgeye Risk Management LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to Perrigo Q3 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.

Seekingalpha | 1 month ago
Here's What Key Metrics Tell Us About Perrigo (PRGO) Q3 Earnings

Here's What Key Metrics Tell Us About Perrigo (PRGO) Q3 Earnings

While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 month ago

Perrigo Company plc (PIG) FAQ

What is the stock price today?

The current price is €11.43.

On which exchange is it traded?

Perrigo Company plc is listed on NYSE.

What is its stock symbol?

The ticker symbol is PIG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.1%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.8.

When is the next earnings date?

The next earnings report will release on Feb 26, 2026.

Has Perrigo Company plc ever had a stock split?

Perrigo Company plc had 1 splits and the recent split was on Aug 26, 1993.

Perrigo Company plc Profile

Specialty Retail Industry
Consumer Discretionary Sector
Patrick Lockwood-Taylor CEO
XFRA Exchange
IE00BGH1M568 ISIN
IE Country
8,379 Employees
28 Nov 2025 Last Dividend
26 Aug 1993 Last Split
16 Dec 1991 IPO Date

Overview

Perrigo Company plc is a leading provider of over-the-counter health and wellness solutions, aiming to enhance individual well-being across the United States, Europe, and other international markets. Operating through Consumer Self-Care Americas and Consumer Self-Care International segments, Perrigo specializes in the development, manufacture, marketing, and distribution of consumer self-care products. The company's portfolio includes a wide range of products designed to meet the health care needs of consumers, such as upper respiratory, nutrition, digestive health, pain and sleep-aids, oral care products, and more. It also extends its offerings to healthy lifestyle, skin care, women's health, vitamins, minerals, supplements, rare diseases, and other miscellaneous self-care products. With a history dating back to 1887, Perrigo Company plc, headquartered in Dublin, Ireland, has evolved from its original name, Perrigo Company, reflecting its growth and international presence.

Products and Services

  • Upper Respiratory Products

    Includes cough suppressants, expectorants, and solutions for sinus and allergy relief. These products are designed to alleviate symptoms associated with colds, flu, and allergies, improving respiratory health.

  • Nutrition Products

    Comprising infant formulas and nutritional beverages formulated to provide essential nutrients and support for infants and adults, ensuring optimal growth and health.

  • Digestive Health Products

    Features antacids, anti-diarrheal, and anti-heartburn medications aimed at offering relief from various digestive issues, enhancing overall digestive wellness.

  • Pain and Sleep-Aids Products

    Encompasses pain relievers and fever reducers in addition to products that help with sleep, addressing minor aches and pains as well as promoting restful sleep.

  • Oral Care Products

    Includes toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers, designed to maintain oral hygiene and health.

  • Healthy Lifestyle Products

    Offers products for smoking cessation, well-being, and weight management, supporting consumers in achieving a healthier lifestyle and better overall health.

  • Skin Care Products

    Covers dermatological care, scar management, lice treatment, and other products for various skin conditions, aimed at promoting healthy skin.

  • Women's Health Products

    Comprises feminine hygiene and contraceptives, addressing women’s health needs with discreet and effective solutions.

  • Vitamins, Minerals, and Supplements

    Provides a wide array of vitamins, minerals, and supplements designed to support overall health and compensate for dietary deficiencies.

  • Rare Diseases Business

    Offers specialized products aimed at treating rare diseases, fulfilling the needs of patients with uncommon medical conditions.

  • Miscellaneous Self-Care Products

    Includes an assortment of additional self-care products catering to a variety of health and well-being needs.

  • Contract Manufacturing Services

    Perrigo also offers contract manufacturing services, providing expertise in the production of high-quality products for third parties.

The company markets its products under several renowned brands, including Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette. These products are distributed through various channels, including retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies, ensuring wide accessibility for consumers.

Contact Information

Address: The Sharp Building
Phone: 353 1 709 4000